Rafael Holdings (RFL) Market Capitalization (2018 - 2026)
Rafael Holdings' (RFL) quarterly Market Capitalization came in at $65.0 million in Q2 2026, up 30.16% year-over-year from $50.0 million in Q2 2025, and up 9.46% quarter-over-quarter from $59.4 million in Q1 2026.
Analysis
Rafael Holdings (RFL) Market Capitalization (2018 - 2026) Analysis & Trends
Rafael Holdings (RFL) has reported Market Capitalization for 9 consecutive years, with $65.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Market Capitalization rose 30.16% year-over-year to $65.0 million in Q2 2026; TTM through Apr 2026 was $65.0 million, a 30.16% increase from a year earlier, with the FY2025 full-year figure at $87.2 million, up 148.93% from the prior year.
- Market Capitalization was $65.0 million for Q2 2026 at Rafael Holdings, up from $59.4 million in the prior quarter.
- Over five years, Market Capitalization peaked at $87.2 million in Q3 2025 and troughed at $35.0 million in Q3 2024.
- A 5-year average of $52.6 million and a median of $47.4 million in 2022 frame the typical range for Market Capitalization.
- Across the five-year window, Market Capitalization plunged 94.42% in 2022 and jumped 148.93% in 2025, its largest moves.
- Over 5 years, Market Capitalization stood at $41.4 million in 2022, then increased by 0.5% to $41.7 million in 2023, then advanced by 3.92% to $43.3 million in 2024, then soared by 59.81% to $69.2 million in 2025, then fell by 6.0% to $65.0 million in 2026.
- The last three Market Capitalization figures came in at $65.0 million (Q2 2026), $59.4 million (Q1 2026), and $69.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Rafael Holdings | 117.57 Mn | 117.57 Mn | 171,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 65.03 Mn |
| Jan 31, 2026 | 59.41 Mn |
| Oct 31, 2025 | 69.18 Mn |
| Jul 31, 2025 | 87.16 Mn |
| Apr 30, 2025 | 49.96 Mn |
| Jan 31, 2025 | 65.02 Mn |
| Oct 31, 2024 | 43.29 Mn |
| Jul 31, 2024 | 35.02 Mn |
| Apr 30, 2024 | 37.17 Mn |
| Jan 31, 2024 | 42.41 Mn |
| Oct 31, 2023 | 41.66 Mn |
| Jul 31, 2023 | 46.28 Mn |
| Apr 30, 2023 | 48.66 Mn |
| Jan 31, 2023 | 47.75 Mn |
| Oct 31, 2022 | 41.45 Mn |
| Jul 31, 2022 | 47.14 Mn |
| Apr 30, 2022 | 42.36 Mn |
| Jan 31, 2022 | 77.64 Mn |
| Oct 31, 2021 | 148.32 Mn |
| Jul 31, 2021 | 845.32 Mn |